Bios - Lifelong Decisions in MS: Addressing Persistence and Progressing Disease

Rock Heyman, MD
Assistant Professor of Neurology
University of Pittsburgh School of Medicine

Rock Heyman, MD, serves as the director of the Multiple Sclerosis Center. He is active with the National Multiple Sclerosis Society (NMSS) locally and nationally, serving on the national council of clinical advisory committee chairs and the national medical advisory board. He also works with the consortium of MS centers as vice chair for education.

Dr. Heyman's major interest is in the clinical care and education of people with MS. Dr. Heyman has been named to the NMSS Volunteer Hall of Fame and to Woodward and White's Best Doctors list for several years.

Dr. Heyman completed his medical school training at Ohio State University in 1985 and his neurology training at the University of Pittsburgh Medical Center in 1989. He completed a fellowship in electroencephalography in 1990. He is board certified in neurology and sleep disorders medicine.

Frederick E. Munschauer, MD
Professor of Clinical Neurology and Internal Medicine
The State University of New York at Buffalo
School of Medicine and Biomedical Sciences
Buffalo, New York

Frederick E. Munschauer, MD, is a board-certified specialist in neurology and internal medicine with a subspecialty in critical care. He is a professor of clinical neurology and internal medicine at the State University of New York at Buffalo School of Medicine and Biomedical Sciences and serves as interim chairman of the department of neurology, as well as acting chief of The Jacobs Neurological Institute of Kaleida Health, Buffalo, New York.

Dr. Munschauer received his medical degree from McGill University, Montreal, Quebec, Canada, and completed an internship and residency in internal medicine and a residency in neurology at The Johns Hopkins Hospital, Maryland, USA. He also completed a fellowship in neurological and neurosurgical intensive care at The National Hospital for Nervous Disease, London, UK. Dr. Munschauer is a member of the American Academy of Neurology, the American Heart Association, the American Medical Association, the American Society of Neuroimaging, and the Society of Critical Care Medicine.

Dr. Munschauer has researched extensively in the use of interferon-b1a (IFN-b1a) as treatment for relapsing-remitting multiple sclerosis (MS) and was coinvestigator of phase III clinical trials and the CHAMPS study. His publications include the phase III clinical trial results, as well as the rationale for early treatment of MS with IFN-b1a, and managing side effects of IFN-b1a in patients. Dr. Munschauer lectures nationally and internationally on the use of IFN-b1a in patients with MS and is considered one of the leaders in the field of MS treatment.

Shirley O'Leary, RN, MSCN
Multiple Sclerosis Center
Texas Neurology

Shirley O'Leary, RN, MSCN, practices with J. Theodore Phillips, MD, at the Multiple Sclerosis Center at Texas Neurology. Over the last 10 years she has been involved in all aspects of patient care, including MS research. She is a member of the International Organization of MS Nurses and the American Association of Neuroscience Nurses and has collaborated on several published MS articles.